RE: Exciting but overpriced.24 Jul 2020 13:50
MF I have done my research. At the moment we have a MCAP of circa £300m . 79% of patients respond to the treatment, it can be administered at any stage of infection and death rates are at the moment zero. The world economies are spending trillions of $ supporting economies with stimulus packages and you think the company is over valued. £4 before a JV or TO announcement